Lin, M.-Y.; Chang, Y.-C.; Wang, S.-Y.; Yang, M.-H.; Chang, C.-H.; Hsiao, M.; Kitsis, R.N.; Lee, Y.-J.
OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer. Antioxidants 2021, 10, 1808.
https://doi.org/10.3390/antiox10111808
AMA Style
Lin M-Y, Chang Y-C, Wang S-Y, Yang M-H, Chang C-H, Hsiao M, Kitsis RN, Lee Y-J.
OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer. Antioxidants. 2021; 10(11):1808.
https://doi.org/10.3390/antiox10111808
Chicago/Turabian Style
Lin, Min-Ying, Yu-Chan Chang, Shan-Ying Wang, Muh-Hwa Yang, Chih-Hsien Chang, Michael Hsiao, Richard N. Kitsis, and Yi-Jang Lee.
2021. "OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer" Antioxidants 10, no. 11: 1808.
https://doi.org/10.3390/antiox10111808
APA Style
Lin, M. -Y., Chang, Y. -C., Wang, S. -Y., Yang, M. -H., Chang, C. -H., Hsiao, M., Kitsis, R. N., & Lee, Y. -J.
(2021). OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer. Antioxidants, 10(11), 1808.
https://doi.org/10.3390/antiox10111808